Indeed, Nrf2 activation has been observed in various cancer types, including bladder cancer, breast cancer, cervical cancer, colon cancer, gastric cancer, globlastoma, glioma, hepatocellular carcinoma, lung cancer, multiple myeloma, pancreatic cancer, and ovarian cancer (Zimta et al., 2019). Here, NFE2L2 is linked to breast carcinoma.